What happened to drug trials in ulcerative colitis? Problems, PPARs, placebos, and (possible) progress
- PMID: 11774930
- DOI: 10.1111/j.1572-0241.2001.05319.x
What happened to drug trials in ulcerative colitis? Problems, PPARs, placebos, and (possible) progress
Comment on
-
An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.Am J Gastroenterol. 2001 Dec;96(12):3323-8. doi: 10.1111/j.1572-0241.2001.05333.x. Am J Gastroenterol. 2001. PMID: 11774944
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical